← SynDRA
VIXOTRIGINE
SynDRA canonical compound SYN0038168 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MAOB | SCN3A | SCN9A |
|---|
| Mechanism of action | sodium channel blocker |
|---|
All known targets
Mechanisms of action (all sources)
- SCN9A BLOCKER
- Sodium channel protein type IX alpha subunit blocker
- SCN9A INHIBITOR
- sodium channel blocker
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SCN10A
- SCN5A
- SCN4A
- ABCB1
- SLCO1B1
- SLC22A6
- SLC22A2
- SCN8A
- SCN7A
- SCN2A
- SCN1A
- MAOA
- ABCG2
- KCNH2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C8
- CYP2C19
- CYP2B6
- CYP2A6
- CYP1A2
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Vixotrigina
- Raxatrigine
- BIIB-074
- BIIB074
- CNV-1014802
- CNV1014802
- GSK-1014802
- GSK1014802
- CNV1014082
- BC600719
- HY-12796
- B5927
- (5R)-5-(4-[2-
- CNV 1014802
- GSK 1014802
- BIIB 074
- QQS4J85K6Y
- vixotriginum
- RefChem:905908
- DTXCID901516865
- Vixotrigine [USAN]
- Raxatrigine (GSK1014802)
- Raxatrigine [USAN]
- GSK1014802(CNV1014802)
- UNII-QQS4J85K6Y
- MFCD22580419
- Gsk-1014802;cnv1014802
- BIIB 074,Vixotrigine
- GSK2
- VIXOTRIGINE [INN]
- Vixotrigine (USAN/INN)
- raxatrigine (deleted INN)
- VIXOTRIGINE [WHO-DD]
- SCHEMBL310473
- orb1305637
- SCHEMBL29385387
- GTPL12645
- JESCETIFNOFKEU-SJORKVTESA-N
- GLXC-90406
Look up VIXOTRIGINE in the interactive SynDRA portal →